Shenyang Xingqi Pharmaceutical Co.,Ltd.

XSEC:300573 Stock Report

Market Cap: CN¥14.4b

Shenyang Xingqi PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 6/6

Shenyang Xingqi PharmaceuticalLtd has a total shareholder equity of CN¥1.6B and total debt of CN¥230.2M, which brings its debt-to-equity ratio to 14.1%. Its total assets and total liabilities are CN¥2.2B and CN¥558.0M respectively. Shenyang Xingqi PharmaceuticalLtd's EBIT is CN¥389.8M making its interest coverage ratio -190.1. It has cash and short-term investments of CN¥503.3M.

Key information

14.1%

Debt to equity ratio

CN¥230.18m

Debt

Interest coverage ratio-190.1x
CashCN¥503.31m
EquityCN¥1.63b
Total liabilitiesCN¥558.01m
Total assetsCN¥2.19b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300573's short term assets (CN¥947.7M) exceed its short term liabilities (CN¥483.3M).

Long Term Liabilities: 300573's short term assets (CN¥947.7M) exceed its long term liabilities (CN¥74.8M).


Debt to Equity History and Analysis

Debt Level: 300573 has more cash than its total debt.

Reducing Debt: 300573's debt to equity ratio has reduced from 15.9% to 14.1% over the past 5 years.

Debt Coverage: 300573's debt is well covered by operating cash flow (194.3%).

Interest Coverage: 300573 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies